<SEC-DOCUMENT>0001193125-16-513640-index.html : 20160322
<SEC-HEADER>0001193125-16-513640.hdr.sgml : 20160322
<ACCEPTANCE-DATETIME>20160322172433
ACCESSION NUMBER:		0001193125-16-513640
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20160108
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160322
DATE AS OF CHANGE:		20160322

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		161521800

	BUSINESS ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d137565d8ka.htm
<DESCRIPTION>FORM 8-K/A
<TEXT>
Document 1 - file: d137565d8ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d137565dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
Document 2 - file: d137565dex21.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d137565dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d137565dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>d137565dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 4 - file: d137565dex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g137565g0322064614129.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g137565g0322064614129.jpg

</DOCUMENT>
</SEC-DOCUMENT>